Vanderbilt University Medical Center (VUMC)


 

2020 ASCO Highlights on Recurred/Metastatic ACC: Does Axitinib Increase PFS Rate Compared to Observation? How Does Tipifarnib Affect H&N Tumors With HRAS Mutations?

14 views
September 29, 2020
Comments 0
Login to view comments. Click here to Login